Recent Quotes View Full List My Watchlist Create Watchlist Indicators DJI Nasdaq Composite SPX Gold Crude Oil Hydroworld Market Index Markets Stocks ETFs Tools Overview News Currencies International Treasuries Emergent BioSolutions Inc. Common Stock (NY: EBS ) 8.270 -0.150 (-1.78%) Official Closing Price Updated: 7:00 PM EST, Dec 27, 2024 Add to My Watchlist Quote Overview Detailed Quote Charting Historical Prices News All News News Headlines Press Releases Research Quarterly Reports Insider Filings Other Filings Price and Volume Detailed Quote Volume 1,022,302 Open 8.260 Bid (Size) 8.220 (5) Ask (Size) 8.320 (2) Prev. Close 8.420 Today's Range 7.950 - 8.350 52wk Range 1.420 - 15.10 Shares Outstanding 54,100,000 Dividend Yield N/A Intraday 1 Week 1 Month 3 Month 1 Year 3 Year 5 Year Top News More News Emergent BioSolutions Receives $50 Million Contract Option from BARDA to Procure Doses of CYFENDUS® (Anthrax Vaccine Adsorbed, Adjuvanted) December 16, 2024 From Emergent BioSolutions Via GlobeNewswire War On Drugs 'Has Failed, Completely And Utterly': UN High Commissioner Urges Evidence-Based Solutions December 09, 2024 UN calls for evidence-based, human rights-focused approach to drug policies, declaring the failed war on drugs needs to be abandoned. Urges transformative change and adoption of International... Via Benzinga Performance YTD +219.31% +219.31% 1 Month -18.20% -18.20% 3 Month +10.41% +10.41% 6 Month +21.26% +21.26% 1 Year +234.82% +234.82% More News Read More Why Emergent BioSciences Stock Plummeted Today December 03, 2024 Via The Motley Fool Emergent's Vaccine Production Failure: Contamination Scandal, Investor Backlash, and $40M Settlement November 22, 2024 Via Benzinga From GLD To TSLA: Unlocking Today’s Best Trading Opportunities November 18, 2024 Via Talk Markets Topics Stocks / Equities After Trump's Win, It's Time To Take Profits On Gold November 11, 2024 Via Benzinga Topics Government Exposures Political Overdose Crisis In Shadows Of Elections As Black, Indigenous Americans Deaths Rise November 07, 2024 Via Benzinga Topics Death Exposures Death Mpox Vaccine Player Emergent BioSolutions Stock Jumps On Upbeat Annual Forecast, Expects Smaller Losses In 2024 November 07, 2024 Via Benzinga Crude Oil Rises 1%; US Jobless Claims Increase To 221,000 November 07, 2024 Via Benzinga Exposures Fossil Fuels Gold Gains 1%; Halliburton Posts Weak Q3 Results November 07, 2024 Via Benzinga 12 Health Care Stocks Moving In Thursday's Intraday Session November 07, 2024 Via Benzinga HubSpot Posts Better-Than-Expected Results, Joins Under Armour, Lyft, Wolverine World Wide, Zillow And Other Big Stocks Moving Higher On Thursday November 07, 2024 Via Benzinga The Post-Trump Victory Trade November 07, 2024 Via Benzinga Topics Government Exposures Political 12 Health Care Stocks Moving In Thursday's Pre-Market Session November 07, 2024 Via Benzinga Why Lyft Shares Are Trading Higher By Over 21%; Here Are 20 Stocks Moving Premarket November 07, 2024 Via Benzinga Emergent BioSolutions (EBS) Q3 2024 Earnings Call Transcript November 07, 2024 Via The Motley Fool Topics Earnings Exposures Financial Emergent BioSolutions Supports New Clinical Trial Evaluating the Safety and Efficacy of Brincidofovir in Treating Mpox Virus Across Africa November 06, 2024 From Emergent BioSolutions Via GlobeNewswire Emergent BioSolutions Reports Third Quarter 2024 Financial Results November 06, 2024 From Emergent BioSolutions Via GlobeNewswire Emergent BioSolutions Appoints Dr. Simon Lowry as Chief Medical Officer and Head of Research and Development November 04, 2024 From Emergent BioSolutions Via GlobeNewswire Emergent BioSolutions to Release Third Quarter 2024 Financial Results and Conduct Conference Call on November 6, 2024 October 23, 2024 From Emergent BioSolutions Via GlobeNewswire Emergent BioSolutions Demonstrates Commitment to Increasing Access & Awareness of NARCAN® Nasal Spray to Help Combat the Opioid Epidemic October 08, 2024 From Emergent BioSolutions Via GlobeNewswire What's Going On With Emergent BioSolutions Stock Wednesday? October 02, 2024 Via Benzinga Emergent BioSolutions Announces Closing of $100 Million Asset-Backed Loan Facility October 02, 2024 From Emergent BioSolutions Via GlobeNewswire 12 Health Care Stocks Moving In Thursday's Intraday Session September 26, 2024 Via Benzinga Emergent BioSolutions Announces the Execution of Contract Options Valued at $67.4 Million to Procure Additional TEMBEXA® (brincidofovir) to Support National Preparedness Efforts September 26, 2024 From Emergent BioSolutions Via GlobeNewswire Stock Quote API & Stock News API supplied by www.cloudquote.io Quotes delayed at least 20 minutes. By accessing this page, you agree to the following Privacy Policy and Terms and Conditions.
